832-497-2220 info@mybiogate.com
CHINA FOCUS @San Francisco

The largest China-themed partnering conference during JPM Week

Jan 12, 2020
GRAND HYATT SAN FRANCISCO  Ballroom Level
345 Stockton St, San Francisco, CA, U.S.

1-ON-1 PARTNERING

Meet the right people and achieve your goals through one-to-one meetings.
Our Online partnering platform is now open. Registered attendees will receive sign-in email from Meeting Mojo.

ABOUT CHINA FOCUS @San Francisco

China has embraced a vigorously growing healthcare market in the past decade. Ever since joining ICH in 2017, China has seen increased clinical trials and accelerated new drug and device approval. For biotech and medtech companies outside of China, you need to find the right partners and the right resources to bring your products to China, in order to adapt to difference in culture, regulation, reimbursement, etc. In the meantime, Chinese biotechs are actively seeking global market entry opportunities and oversea partners.

China Focus @San Francisco is a partnering forum designed to provide a meaningful platform to inform, inspire, and foster cross-border partnership in life science and healthcare.

 

Who should attend
  • Investors (VC, PE, investment bank, etc.)
  • Life science innovators and entrepreneurs
  • Biotech & big pharma
  • Medtech (device and diagnostics) manufacturers and distributors
  • Service providers (law firm, financial advisory, regulatory consulting, CRO, CDMO, etc.)
  • Healthcare providers
MAIN TOPICS
  • Cross-border investment: money from the East and the West
  • Innovations going to China: regulation, market access, manufacturing and distribution
  • Chinese innovations going west: partnership for capital and market access in the U.S.
WHAT YOU CAN GET
  • Learn about Chinese life science and healthcare industry
  • Hear about the latest Chinese regulatory reforms and implications
  • Meet with the decision makers in the industry
  • Initiate business conversations that otherwise difficult to start

Agenda

  PLENARY SESSION

7:00-8:00

Check in and free networking

8:00-8:20

Opening Remarks

Xinxin Li, VP of Strategic Partnerships, MyBioGate

8:20-9:20

Keynote speeches

Discovering HER2, Herceptin – And Opportunities for Future Breakthroughs through Global-American-Chinese Research Collaboration – 2019 Lasker Award winner; Herceptin inventor, H. Michael Shepard
Global life science and healthcare investment and finance 2019 – Katherine Andersen, Head of Life Science & Healthcare, Silicon Valley Bank

9:20-10:50

Chinese companies’ road to world-class corporations

Moderator: Helen Chen – Greater China Managing Partner, L.E.K. Consulting
Internationalization of Chinese companies in Healthcare – Dajian Cai, GTJA Investment Group
Phoenix Reborn--Innovative R&D Strategy and Plan of Gloria Biosciences – Helena Meng, VP and CMO, Gloria Biosciences
Rising China Biotech: The CStone Story – Shirley Zhao, CStone Pharma
Opportunities and challenges in China healthcare market – Helen Chen, L.E.K. Consulting
Fireside chat
Dajian Cai – Chairman, GTJA Investment Group
Shirley Zhao – Great China General Manager & Head of Commercial, CStone Pharma
Austin Zhu – President of Gloria Pharmaceuticals, General Manager of Gloria Biosciences

10:50-11:40

Panel 1 – New landscape and trends of investment in life science & healthcare

Moderator: Kim Nearing – Venture Partner, BVCF Management, ltd.
Panelists:
James Huang – Founding Partner, Panacea Venture; Managing Partner, KPCB China
Amy Tang – Venture Partner, Qiming Venture Partners
Bo Liu – Executive VP & Managing Director- Healthcare Investments, CDIB Capital
John Zhu – Partner, 6 Dimensions Capital
Mark Tang – Managing Director, Good Health Capital
Wendy Pan – Partner, Goodwin LLP

11:50-12:30

Medical device elevator pitch

12:30-13:30

Lunch Break

13:30-14:15

Panel 2 – China market needs for medical devices

Moderator: Tianji Zhu, VP, CD Capital
Panelists:
Yonghui Shi – Managing Director, Metronic China Fund
Adam Zha – Partner, Anlong Fund
Yu Fang – Partner, 3E Bioventures Capital
Drake Yu – Founding Partner, LYFE Capital

14:15-15:00

Fireside Chat – MNC vs. Domestic: strategies to meet new opportunities and challenges in the China market

Moderator: Dennis Purcell – Founder and Senior Advisor, Aisling Capital
Guest speakers:
Wei Jiang – Executive Vice President and President, Bayer Pharmaceuticals Region China & APAC;
President, Bayer Group Greater China

15:00-15:15

Introduction of Nanjing Jiangbei New District

Chunmei Chen – Chanmei Chen – Executive Deputy Director of Nanjing Municipal Jiangbei New Area Administrative Committee

15:15-15:30

Break

15:30-16:15

Panel 3 – Market needs and access in China (Panel Partner: BioKatalyst)

Moderator: Paul Zhang – Partner, Bluestar Bioadvisors LLC; President, BioKatalyst
Panelists:
Bing Yuan – Chief Business Officer, Cstone Pharmaceuticals
Zhimin Jimmy Zhang – Venture Partner, Lilly Asia Ventures
Derek Small - Founding General Manager, Assembly Biosciences Research & Development Co. Shanghai
Jonathan Wang – Senior VP Head, Business Development, Zai Lab
Lingyun Dong – General Manager, Yeedozencom Science & Technology

16:15-17:00

Panel 4 – Chinese pharma’s overseas outreach and collaboration

Moderator: Jun Bao – President and CEO, Impact Therapeutics
Panelists:
Geffrey Gao – Executive VP/Deputy GM, Harbin Pharmaceutical Group
Larry Cai – Executive Director of BD, Fosun pharma
Xiangbin Xu – President, Simcere Innovation Center
Brad Loncar – CEO, Loncar Investments
Lu Cao - US Head of Corporate Banking for Chinese Multinationals, J.P. Morgan

  BREAKOUT A
Morning: AI and Digital health

11:00-12:00

AI and novel therapeutic solutions

Moderator: Echo Hindle-Yang – CEO at M.S.Q. Ventures
Panelists:
Hainian Zeng – CEO, Silexon AI Technology
Alan Jiang – CSO, XtalPi
Andrew Radin – CEO, twoXAR
Guo-liang Yu – Global CEO, Apollomics Inc
Daniel Teper – Co-Founder, Chairman & CEO, CYTOVIA Therapeutics

Afternoon: Session sponsored by YEEDOZENCOM

13:30-14:00

Interpretation of the Latest Pharmaceutical Administration Law of the People's Republic of China and Provisions for Drug Registration.

Zhen Chen – Chief Scientist & Deputy General Manager of Beijing YEEDOZENCOM Healthcare Science & Technology Co., Ltd.

14:00-14:15

Introduction of YEEDOZENCOM

Lingyun Dong – General Manager of Beijing YEEDOZENCOM Healthcare Science & Technology Co., Ltd.

14:15-15:00

Route Exploration of the Drug Marketing Authorization in China

Moderator: Lingyun Dong – General Manager of Beijing YEEDOZENCOM Healthcare Science & Technology Co., Ltd.
Panelists:
Zhen Chen – Chief Scientist & Deputy General Manager of Beijing YEEDOZENCOM Healthcare Science & Technology Co., Ltd.
Xiumin Huo – Professor of YEEHONG Business School
Zhi Xiao – Managing Director, SDIC Fund
Zhenyu Li – Business Development Director of LUNAN PHARMACEUTICAL GROUP CORP.

15:00-15:30

Tea Break

15:30-16:00

Q&A for Medicine Launching Regulations in China Market

Zhen Chen – Chief Scientist & Deputy General Manager of Beijing YEEDOZENCOM Healthcare Science & Technology Co., Ltd.

  BREAKOUT B
Morning: Cell and Gene therapy

10:00-11:00

Technological bottlenecks and breakthroughs in cell and gene therapy

Moderator: Alain Vertès – Managing Director, NxR Biotechnologies GmbH
Panelists:
Zhenhua Wu – CEO, Exegenesis Bio
Lynnet Koh – CEO, Targazyme
Jason Slingby – CBO, Oxford Biomedica
Frank Zhang – CEO, GenScript

Innovation in Jiangsu

11:10-11:40

Jiangsu Industrial Technology Research Institute (JITRI) Introduction

Paul E. Burrows - Vice President of Jiangsu Industrial Technology Research Institute

11:40-11:50

JITRI Southern California Innovation Center Introduction

Calvin Chen - CEO of CrossLinkBio,Inc.

12:00-13:00

Lunch networking with Jiangsu companies and investors

13:00-13:20

Jiangsu Innovative Healthcare Companies Introduction

13:30-14:30

Projects Partnering

14:30-18:00

Medical device company presentation

Company Presentation Track Agenda

10:00-10:05

Opening

Ginger Ding, Director of Investment Analyst, MyBioGate

10:05-12:30

Company Presentation

Torbjorn Furuseth, CFO, Targovax
Lu Wang, Vice President, Flow Pharma
Ben Bobo, Founder & CEO, Cerenetx
Ping Rawson, Chief Financial Officer, Dyadic International
Franz Gruz, CEO, Maintect GmbH
Zhijun Zhang, CSO, Zhimeng Biopharma
Anna Sumeray, CEO, Virometix
Wen Luo, Denovo Biopharma
Scott Christensen, CEO, OncoGenesis
George Simeon, CEO, Curevo Vaccine
Lucy Lu, CFO, Kintor Pharmaceutical Limited

13:30-14:30

Company Presentation

Huiru (Jane) Wang, CEO, Huirui Biopharma
Michael Tardugno, CEO, Celsion
Liming Yang, CEO, Wyze Biotech
Mark Colbrie, CEO, Strateos

14:30-15:15

Gain Insights in Dealmaking by Hearing Real World Case Studies

Zhenhua Wu, CEO, Exegenesis Bio
David Poon, Vice President of Business Development, Zymeworks
Shawn Zhang, VP, Ambrx
Anu Balendran, Vice President Business Development, Alligator Bioscience
Darrin Crisitello, Chief Commercial Officer, Mission Bio
James Lee, Sr. Business Development Manager, Atomwise

15:15-17:30

Company Presentation

Haijin Meng, Vice President, Chief Medical Officer, Gloria Biosciences
Sean Hu, CEO, Avotres
Peter Fedichev, CEO, Gero
Ying Chen, Senior Vice President of Marketing, Bayer Pharmaceuticals
Jiang Li, CEO, VivaLNK
Henry Oconnell, CEO, Canary Speech
Patrick Lopath, Co-founder and COO, TECLens, LLC
Chris Lai, CEO, METiS Pharmaceuticals
Mahmoud Rafea, Chief Scientist, Erythra

FEATURED SPEAKERS

Dajian Cai

Chairman
GTJA Investment Group

James Huang

Managing Partner, KPCB China
Founding Partner, Panacea Venture

Katherine Andersen

Head of U.S. Life Science & Healthcare Relationship Banking
Silicon Valley Bank

Amy Tang

Venture Partner
Qiming Venture Partners

Kim Nearing

Managing Director
Cedrus Group

Bing Yuan

Chief Business Officer
CStone Pharmaceuticals

Derek Small

Director & Senior Advisor, former CEO
Assembly Bio

Paul Zhang

Partner
Bluestar BioAdvisors, LLC

Brad Loncar

CEO
Loncar Investments

Helen Chen

Greater China Managing Partner
L.E.K Consulting

Bo Liu

Managing Director
CDIB Capital

Jimmy Zhang

Venture Partner
Lilly Asian Ventures

John Zhu

Partner
6 Dimensions Capital

Dennis Purcell

Founder and Senior Advisor
Aisling Capital

Dekel Gelbman

CEO
FDNA

Hai-Nian Zeng

CEO
Silexon AI Technology

Zhenhua Wu

President and CEO
Exegenesis Bio

Shawn Xu

Executive Director
Simcere Innovation, Inc.

Jun Bao

President and CEO
Impact Therapeutics

Zonghai Li

CEO and CSO
CARsgen Therapeutics

Alan Jiang

CSO
XtalPi

Alain Vertès

Managing Director
NxR Biotechnologies GmbH

Mark Tang

Founding Partner
Good Health Capital

Geffrey Gao

Executive VP/Deputy GM
Harbin Pharmaceutical Group

Yong-Hui Shi

Head and Sr. Managing Director
Medtronic China Ventures

Andew A. Radin

CEO
twoXAR

Platinum SPONSOR
Gold SPONSOR
ATTENDEE DEMOGRAPHICS
at Previous China Focus Events

Attendees

Chinese Companies and Investors

%

Executive Level Attendees

One-to-one meetings

CHINA FOCUS @ JPM WEEK 2019

Panel 1: Money from the East: Opportunities and Challenges in Cross-border Collaboration

CHINA FOCUS @ JPM WEEK 2019

Panel 2: Partnering Opportunities with Chinese Pharma Companies

CHINA FOCUS @ JPM WEEK 2019

Panel 3: Selling to the West: Fund raising, Out-licensing and IPO Opportunities for China′ s Biotech Innovations

CHINA FOCUS @ JPM WEEK 2019

Panel 4: Current Healthcare Venture Capital Trends & Opportunities

InvestoRs
Qualified investors can request complimentary registration
MEDIA  REGISTRATION
Member of the press can request for a complimentary regisitration

Call for Sessions is now open for the China Focus@San Francisco! Create your session with us, you are more than just a listener.

Contact Us

7 + 7 =

Registration, Sponsorship and Collaboration (China)

Youwen (Allen) Dai

youwen.dai@mybiogate.com

Registration, Sponsorship and Collaboration (U.S. and Europe)

Xinxin Li

Xinxin.li@mybiogate.com
Speaker, Group Delegation and Presenting Companies

Han Yan

han.yan@mybiogate.com

 

FORUM VENUE

Address:

GRAND HYATT SAN FRANCISCO
345 Stockton Street
San Francisco, CA 94108, USA

Phone: +1 415 398 1234
Fax: +1 415 391 1780